These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 31240525)

  • 41. Prognostic Value of a Category Based on Electron Microscopic Features of Clival Chordomas.
    Bai J; Zhai Y; Wang S; Gao H; Du J; Wang J; Li M; Li C; Gui S; Zhang C; Sun Y; Zhang Y
    World Neurosurg; 2017 Mar; 99():282-287. PubMed ID: 27916725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multimodality management of 26 skull-base chordomas with 4-year mean follow-up: experience at a single institution.
    Pamir MN; Kiliç T; Türe U; Ozek MM
    Acta Neurochir (Wien); 2004 Apr; 146(4):343-54; discusion 354. PubMed ID: 15057528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma.
    Zhang L; Guo S; Schwab JH; Nielsen GP; Choy E; Ye S; Zhang Z; Mankin H; Hornicek FJ; Duan Z
    PLoS One; 2013; 8(9):e75851. PubMed ID: 24086644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of hepatocyte growth factor and c-MET in skull base chordoma.
    Naka T; Kuester D; Boltze C; Scheil-Bertram S; Samii A; Herold C; Ostertag H; Krueger S; Roessner A
    Cancer; 2008 Jan; 112(1):104-10. PubMed ID: 17948912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chordomas: A review with emphasis on their pathophysiology, pathology, molecular biology, and genetics.
    Karpathiou G; Dumollard JM; Dridi M; Dal Col P; Barral FG; Boutonnat J; Peoc'h M
    Pathol Res Pract; 2020 Sep; 216(9):153089. PubMed ID: 32825957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intradural chordoma presenting with intratumoral bleeding.
    Vellutini Ede A; de Oliveira MF
    J Clin Neurosci; 2016 Mar; 25():139-42. PubMed ID: 26563604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. From notochord formation to hereditary chordoma: the many roles of Brachyury.
    Nibu Y; José-Edwards DS; Di Gregorio A
    Biomed Res Int; 2013; 2013():826435. PubMed ID: 23662285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Classic chordoma coexisting with benign notochordal cell rest demonstrating different immunohistological expression patterns of brachyury and galectin-3.
    Shen J; Li CD; Yang HL; Lu J; Zou TM; Wang DL; Deng M
    J Clin Neurosci; 2011 Jan; 18(1):96-9. PubMed ID: 20855213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical features and surgical outcomes of patients with skull base chordoma: a retrospective analysis of 238 patients.
    Wang L; Wu Z; Tian K; Wang K; Li D; Ma J; Jia G; Zhang L; Zhang J
    J Neurosurg; 2017 Dec; 127(6):1257-1267. PubMed ID: 28059654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence-Based Optimization of Post-Treatment Surveillance for Skull Base Chordomas Based on Local and Distant Disease Progression.
    Freeman JL; Kaufmann AB; Everson RG; DeMonte F; Raza SM
    Oper Neurosurg (Hagerstown); 2019 Jan; 16(1):27-36. PubMed ID: 29912434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
    Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL
    Anticancer Res; 2013 Jun; 33(6):2381-90. PubMed ID: 23749886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment.
    Mathios D; Ruzevick J; Jackson CM; Xu H; Shah SR; Taube JM; Burger PC; McCarthy EF; Quinones-Hinojosa A; Pardoll DM; Lim M
    J Neurooncol; 2015 Jan; 121(2):251-9. PubMed ID: 25349132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of Gamma Knife surgery in the treatment of skull base chordomas.
    Dassoulas K; Schlesinger D; Yen CP; Sheehan J
    J Neurooncol; 2009 Sep; 94(2):243-8. PubMed ID: 19277468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Difference in the hypoxic immunosuppressive microenvironment of patients with neurofibromatosis type 2 schwannomas and sporadic schwannomas.
    Tamura R; Morimoto Y; Sato M; Kuranari Y; Oishi Y; Kosugi K; Yoshida K; Toda M
    J Neurooncol; 2020 Jan; 146(2):265-273. PubMed ID: 31897926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2 in primary and recurrent WHO grade III meningiomas.
    Baumgarten P; Brokinkel B; Zinke J; Zachskorn C; Ebel H; Albert FK; Stummer W; Plate KH; Harter PN; Hasselblatt M; Mittelbronn M
    Histol Histopathol; 2013 Sep; 28(9):1157-66. PubMed ID: 23475388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis.
    Oakley GJ; Fuhrer K; Seethala RR
    Mod Pathol; 2008 Dec; 21(12):1461-9. PubMed ID: 18820665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal Carcinoma.
    Nasir A; Reising LO; Nedderman DM; Fulford AD; Uhlik MT; Benjamin LE; Schade AE; Holzer TR
    Anticancer Res; 2016 Jun; 36(6):2683-96. PubMed ID: 27272777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor Infiltrating Effector Regulatory T Cells Express VEGF Receptor 2 in Patients With Colorectal Cancer.
    Tsumuraya H; Mimura K; Nakajima S; Hanayama H; Matsuishi A; Okayama H; Fukai S; Ito M; Ashizawa M; Chida S; Onozawa H; Sakamoto W; Saito M; Saze Z; Momma T; Kono K
    Anticancer Res; 2024 Jul; 44(7):2933-2941. PubMed ID: 38925828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.
    Dikov MM; Ohm JE; Ray N; Tchekneva EE; Burlison J; Moghanaki D; Nadaf S; Carbone DP
    J Immunol; 2005 Jan; 174(1):215-22. PubMed ID: 15611243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spinal column chordoma: prognostic significance of clinical variables and T (brachyury) gene SNP rs2305089 for local recurrence and overall survival.
    Bettegowda C; Yip S; Lo SL; Fisher CG; Boriani S; Rhines LD; Wang JY; Lazary A; Gambarotti M; Wang WL; Luzzati A; Dekutoski MB; Bilsky MH; Chou D; Fehlings MG; McCarthy EF; Quraishi NA; Reynolds JJ; Sciubba DM; Williams RP; Wolinsky JP; Zadnik PL; Zhang M; Germscheid NM; Kalampoki V; Varga PP; Gokaslan ZL;
    Neuro Oncol; 2017 Mar; 19(3):405-413. PubMed ID: 27663388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.